Home Data Calendar Blog

KYMR

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Common Stock Value 0.010.010.010.010.010.010.000.00NANANANANA
Weighted Average Number Of Diluted Shares Outstanding 54.5451.77NANA50.7145.09NANANANANANANA
Weighted Average Number Of Shares Outstanding Basic 54.5451.77NANA50.7145.09NANANANANANANA
Weighted Average Number Of Share Outstanding Basic And Diluted NANA51.65NA50.7145.0944.65NA20.682.001.95NA1.75
Earnings Per Share Basic -0.79-0.78NANA-0.56-0.55NANANANANANANA
Earnings Per Share Diluted -0.79-0.78NANA-0.56-0.55NANANANANANANA
Earnings Per Share Basic And Diluted NANA-0.71-0.67-0.56-0.55-0.291.96-0.39-6.98-10.23-6.13-6.54

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Revenue From Contract With Customer Excluding Assessed Tax 9.5511.519.6215.2820.3418.5218.7012.7914.533.293.431.830.95
Revenues 9.5511.519.6215.2820.3418.5218.7012.7914.533.293.431.830.95
Operating Expenses 54.4352.3246.5549.2748.9743.2531.8725.5722.6217.4814.6813.6212.81
Research And Development Expense 43.8841.2935.9437.5338.3135.2225.9620.3915.7813.8212.1211.0911.31
General And Administrative Expense 10.5611.0310.6111.7410.678.035.915.176.843.662.562.531.50
Operating Income Loss -44.88-40.81-36.93-33.99-28.64-24.73-13.17-12.78-8.08-14.19-11.25-11.78-11.86
Interest Paid Net 0.040.040.050.050.050.030.020.030.020.030.03NANA
Allocated Share Based Compensation Expense 9.089.627.878.687.405.733.171.832.330.660.370.300.23
Profit Loss -43.00-40.26-36.68-33.90-28.58-24.66-13.07-12.69-7.99-13.99-10.93-11.51NA
Net Income Loss -43.00-40.26-36.68-33.90-28.58-24.66-13.07-12.69-7.99-13.99-10.93-11.51-11.42
Comprehensive Income Net Of Tax -44.93-41.02-39.24-34.41-28.73-24.65-12.96-12.65-8.18-14.18-10.72-11.51-11.42
Net Income Loss Available To Common Stockholders Basic -43.00-40.26-36.68-33.90-28.58-24.66-13.07-12.69-7.99-13.99-19.98-11.51-11.42

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Assets 638.47523.42563.06605.90642.45434.39464.55487.18507.36NANA116.70NA
Liabilities 125.59125.47134.34146.27159.32176.28189.31203.29212.68NANA82.03NA
Liabilities And Stockholders Equity 638.47523.42563.06605.90642.45434.39464.55487.18507.36NANA116.70NA
Stockholders Equity 512.88397.95428.72459.64483.13258.10275.25283.89294.69-107.29-93.80-74.41-63.22

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Assets Current 494.02402.77431.38451.27543.73364.81340.79302.34297.36NANA92.84NA
Cash And Cash Equivalents At Carrying Value 155.6676.9133.7347.98156.8284.9053.1031.0054.5960.97121.2576.025.34
Prepaid Expense And Other Assets Current 9.238.099.318.725.774.795.524.702.95NANA0.89NA
Available For Sale Securities Debt Securities 439.95405.58489.56519.63454.26319.51382.08427.73426.71NANA15.94NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Property Plant And Equipment Gross 18.6418.0516.3615.8015.4115.2913.3812.9912.64NANA4.84NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 6.085.314.603.923.233.182.622.151.65NANA1.05NA
Property Plant And Equipment Net 12.5712.7511.7611.8812.1812.1210.7510.8410.98NANA3.79NA
Other Assets Noncurrent 3.022.432.022.020.720.920.030.031.59NANA1.77NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Liabilities Current 91.1287.5088.3492.5494.49108.69110.14110.62107.29NANA34.57NA
Accounts Payable Current 6.332.372.574.005.038.188.354.373.98NANA3.28NA
Other Accrued Liabilities Current 0.190.640.340.350.560.260.020.010.71NANA0.09NA
Accrued Liabilities Current 24.6921.7420.7822.9719.2214.6710.5710.337.87NANA4.57NA
Other Liabilities Current 0.710.270.580.230.380.110.260.11NANANANANA
Contract With Customer Liability Current 55.7859.4660.8561.7466.2382.2687.9192.5592.01NANA23.35NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Other Liabilities Noncurrent 0.260.260.270.070.080.080.090.10NANANANANA
Operating Lease Liability Noncurrent 12.4312.7112.9813.2213.4613.7013.9214.1314.33NANA16.65NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Stockholders Equity 512.88397.95428.72459.64483.13258.10275.25283.89294.69-107.29-93.80-74.41-63.22
Common Stock Value 0.010.010.010.010.010.010.000.00NANANANANA
Additional Paid In Capital Common Stock 867.72707.85697.60689.27678.36424.60417.10412.78410.93NANA2.04NA
Retained Earnings Accumulated Deficit -348.93-305.92-265.67-228.98-195.08-166.50-141.84-128.76-116.08NANA-76.46NA
Accumulated Other Comprehensive Income Loss Net Of Tax -5.91-3.98-3.22-0.66-0.15NA-0.01-0.13-0.16NANA0.01NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 9.089.627.878.687.405.733.171.832.330.660.370.300.23

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Net Cash Provided By Used In Operating Activities -34.27-38.98-40.30-38.35-37.26-30.51-22.82-20.07131.67-11.41-12.06-10.80NA
Net Cash Provided By Used In Investing Activities -37.4881.8025.86-68.02-136.8660.7244.32-3.99-334.32-46.87-37.4061.96NA
Net Cash Provided By Used In Financing Activities 150.500.360.182.05246.041.590.590.27196.28-0.4093.1221.09NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Net Cash Provided By Used In Operating Activities -34.27-38.98-40.30-38.35-37.26-30.51-22.82-20.07131.67-11.41-12.06-10.80NA
Net Income Loss -43.00-40.26-36.68-33.90-28.58-24.66-13.07-12.69-7.99-13.99-10.93-11.51-11.42
Profit Loss -43.00-40.26-36.68-33.90-28.58-24.66-13.07-12.69-7.99-13.99-10.93-11.51NA
Depreciation Depletion And Amortization 0.770.700.690.690.670.550.480.500.490.390.390.36NA
Increase Decrease In Other Operating Capital Net 0.170.72-0.55NA-0.300.89-0.14NANANANANANA
Increase Decrease In Accounts Payable 4.17-0.41-1.44-1.03-2.92-0.144.150.470.90-0.21-0.161.41NA
Share Based Compensation 9.089.627.878.687.405.733.171.832.330.660.370.30NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Net Cash Provided By Used In Investing Activities -37.4881.8025.86-68.02-136.8660.7244.32-3.99-334.32-46.87-37.4061.96NA
Payments To Acquire Property Plant And Equipment 1.250.730.480.500.310.630.161.442.413.851.400.20NA
Payments To Acquire Investments 153.9164.7180.12NA245.8430.1516.01NA350.4174.5236.01NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Net Cash Provided By Used In Financing Activities 150.500.360.182.05246.041.590.590.27196.28-0.4093.1221.09NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Revenues 9.5511.519.6215.2820.3418.5218.7012.7914.533.293.431.830.95
Collaboration Target One, Sanofi Collaboration Arrangement 4.500.509.50NA14.5012.009.50NANANANANANA
Collaboration Target Two, Sanofi Collaboration Arrangement 2.602.902.10NA2.002.402.10NANANANANANA
Sanofi Collaboration Arrangement 7.103.4011.60NA16.5014.4011.60NANANANANANA
Vertex Agreement 2.503.103.003.403.804.107.104.903.603.303.401.801.00
Revenue From Contract With Customer Excluding Assessed Tax 9.5511.519.6215.2820.3418.5218.7012.7914.533.293.431.830.95
Collaboration Target One, Sanofi Collaboration Arrangement 4.500.509.50NA14.5012.009.50NANANANANANA
Collaboration Target Two, Sanofi Collaboration Arrangement 2.602.902.10NA2.002.402.10NANANANANANA
Sanofi Collaboration Arrangement 7.103.4011.60NA16.5014.4011.60NANANANANANA
Vertex Agreement 2.503.103.003.403.804.107.104.903.603.303.401.801.00

Plots across concepts


IncomeStatement
Comprehensive Income Net Of Tax
Expenses
Other Nonoperating Income Expense
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Operating Lease Right Of Use Asset
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Operating Lease Liability
Current Liabilities
Other Accrued Liabilities Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Share Outstanding Basic And Diluted
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:TypeOfArrangement
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:TypeOfArrangement
(None, 'kymr:SanofiCollaborationArrangement')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Research And Development Arrangement Contract To Perform For Others By Type, us-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:TypeOfArrangement
(None,)
Revenuesus-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:TypeOfArrangement
(None, 'kymr:SanofiCollaborationArrangement')
Revenuesus-gaap: Research And Development Arrangement Contract To Perform For Others By Type, us-gaap: Type Of Arrangement
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
(None,)
Allocated Share Based Compensation Expenseus-gaap: Award Type
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:MarketableSecuritiesCurrent
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType
('us-gaap:FairValueInputsLevel1', 'us-gaap:FairValueMeasurementsRecurring', None)
Marketable Securities Currentus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Investment Type
us-gaap:MarketableSecuritiesCurrent
us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType
('us-gaap:FairValueMeasurementsRecurring', None)
Marketable Securities Currentus-gaap: Fair Value By Measurement Frequency, us-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:Revenues
us-gaap:TypeOfArrangement
(None,)
Revenuesus-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:TypeOfArrangement
(None, 'kymr:SanofiCollaborationArrangement')
Revenuesus-gaap: Research And Development Arrangement Contract To Perform For Others By Type, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:TypeOfArrangement
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:TypeOfArrangement
(None, 'kymr:SanofiCollaborationArrangement')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Research And Development Arrangement Contract To Perform For Others By Type, us-gaap: Type Of Arrangement